Immune Repertoire Sequencing Market To Witness Moderate Growth 5.6 % CAGR till 2026 – Coherent Market Insights
Global Immune Repertoire Sequencing Market, by Product Type (Assay Kits (T-cell Receptor Kits and B-cell Receptor Kits) and Instruments), By Application (Cancer Immunotherapy, Biomarker Discovery, Autoimmune Diseases, Vaccine Development and Efficacy, Transplant Rejection and Tolerance, Infectious Diseases, and Other Applications), By End User (Diagnostic Labs, Biotechnology and Pharmaceutical Companies, Academic and Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 114.3 million in 2017 and is expected to exhibit a CAGR of 5.6% over the forecast period (2018-2026), as highlighted in a new report published by Coherent Market Insights.
Global Immune Repertoire Sequencing Market
Immune repertoire sequencing is extensively used in biomarker discovery in order to improve the success rate and cost-effectiveness of rational drug development. In November, 2017, the Center for Commercialization of Cancer Immunotherapy (C3i) started offering T cell receptor-beta sequencing services in its Biomarker and Diagnostics unit in Canada. Increasing demand for personalized medicine is expected to aid the global immune repertoire sequencing market growth, as personalized medicine uses an individual’s genetic profile to guide the decisions made in regards to the diagnosis, prevention, and treatment of the disease they are suffering from.
Get an exclusive sample copy of the business report: https://www.coherentmarketinsights.com/insight/request-sample/1517
Burgeoning Demand for Genomic and Repertoire Sequencing-based Research to Fuel Market Growth
The global immune repertoire sequencing market was valued at US$ 114.3 million in 2017, and is expected to witness a CAGR of 5.6% over the forecast period (2018-2026).
Global Immune Repertoire Sequencing Market Share (%) Analysis, By Product Type, 2017
Source: Coherent Market Insights Analysis (2018)
Increasing research and development and launches of novel products by key players are expected to be the major driving force for global immune repertoire sequencing market growth in the near future. For instance, in 2016, ArcherDX, Inc. expanded its product portfolio with the launch of Archer Immunoverse immune repertoire sequencing assays at the American Society of Hematology (ASH). In 2017, ArcherDX, Inc. launched Archer Immunoverse B Cell Receptor (BCR) assays to characterize the human B cell repertoire.
According to a study published by the Cold Spring Harbor Laboratory in 2017, a team of researchers from the Stanford University applied the immune repertoire sequencing method to identify disease-related signatures in the immune systems of patients with systemic sclerosis-related pulmonary hypertension (SSc-PAH), which is a rare chronic autoimmune disease affecting the connective tissue. Therefore, increasing research on immune repertoire sequencing is expected to create a conducive environment for the global immune repertoire sequencing market growth.
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 25% OFF On Any Research Report
Apply Promo Code “CHRISTMAS2020” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1517
Global Immune Repertoire Sequencing Market Restraints
Challenges in immune repertoire sequencing include distinguishing biological variations from the errors and the bias introduced in different steps. Conventional and novel bioinformatics techniques such as high throughput screening, Haystack Heuristic, and others are not up to the mark due to unsatisfactory scalability and sensitivity, and limitation in providing sufficient and accurate data. Moreover, the differences of data generation and processing in different laboratories along with the challenges in immune repertoire sequencing system are some key factors, which may hamper growth of the immune repertoire sequencing market size.
Global Immune Repertoire Sequencing Market – Regional Insights
North America is expected to hold a dominant position in the global immune repertoire sequencing market during the forecast period, owing to high presence of key industry players in the region, including Illumina Inc., Thermo Fisher Scientific, Pacific Biosciences, and CD Genomics. These players are increasingly focusing on the development of novel technologies for immune repertoire sequencing. For instance, in 2017, 10x Genomics Inc., U.S. based company, added B-Cell and 5’Unbiased Enrichment Kit to its chromium immune repertoire profiling solution or immune repertoire sequencing.
The immune repertoire sequencing market in Europe is expected to gain momentum during the forecast period, owing to the increased funding by the government bodies to support international innovative projects and marketable innovative products, processes, and services, in order to cater to the unmet medical needs. In July 2018, Eurostars (a joint program between EUREKA and the European Commission) granted US$ 495,000 to OSE Immunotherapeutic SA’s project entitled: ‘Treatment Response Monitoring for Cancer Immunotherapies Using Immune Repertoire Analysis’.
Global Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2026
Source: Coherent Market Insights Analysis (2018)
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/immune-repertoire-sequencing-market-to-surpass-us-185-million-by-2026-1273
Global Immune Repertoire Sequencing Market – Competitive Outlook
The most prominent players operating in the global immune repertoire sequencing market include Thermo Fisher Scientific, Inc., Illumina Inc., ArcherDX, Inc., Roche Holding AG, Pacific Biosciences, CD Genomics, Atreca, Inc., Adaptive Biotechnologies, Oxford Nanopore Technologies, Ltd., Qiagen N.V., Agilent Technologies, Inc., and Takara Bio, Inc.
Detailed Segmentation:
- Global Immune Repertoire Sequencing Market, By Product Type:
- Assay Kits
- T-Cell Receptor (TCR) Kits
- B-Cell Receptor (BCR) Kits
- Instruments
- Assay Kits
- Global Immune Repertoire Sequencing Market, By Application:
- Cancer Immunotherapy
- Biomarker Discovery
- Autoimmune Diseases
- Vaccine Development and Efficacy
- Transplant Rejection and Tolerance
- Infectious Diseases
- Other Applications
- Global Immune Repertoire Sequencing Market, By End User:
- Diagnostic Labs
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institutes
- Others
- Global Immune Repertoire Sequencing Market, By Region:
- North America
- By Country:
- U.S.
- Canada
- By Product Type:
- By Application:
- By End User:
- By Country:
- Europe
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- By Product Type:
- By Application:
- By End User:
- By Country:
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- By Product Type:
- By Application:
- By End User:
- By Country:
- Latin America
- By Country:
- By Product Type:
- By Application:
- By End User:
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Product Type:
- By Application:
- By End User:
- By Country:
- Africa
- By Country:
- South Africa
- Central Africa
- North Africa
- By Product Type:
- By Application:
- By End User:
- By Country:
- North America
Other Exclusive Reports:
IMMUNE CHECKPOINT INHIBITORS MARKET ANALYSIS
MONOCLONAL ANTIBODIES MARKET ANALYSIS
HUMAN IMMUNOGLOBULIN (PH4) FOR INTRAVENOUS INJECTION MARKET ANALYSIS
About Us:Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.
Editor Details
-
Company:
- CDN Newswire
